COVID-19 患者中补充和整合医学的使用情况及相关因素。
Prevalence and associated factors of complementary and integrative medicine use in patients afflicted with COVID-19.
机构信息
Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
出版信息
BMC Complement Med Ther. 2022 Sep 30;22(1):251. doi: 10.1186/s12906-022-03722-x.
BACKGROUND
Complementary and Integrative Medicine (CIM) is often taken up by individuals seeking relief from different diseases. This study investigates the prevalence and associated factors of CIM use in patients with COVID-19.
METHODS
In this telephone-based, cross-sectional study, data on CIM usage were collected from COVID-19 patients from February till June 2020 in Fars province, Iran using a researcher-made checklist. Additionally, we asked about the patients' attitudes toward these treatments.
RESULTS
Out of 453 patients diagnosed with COVID-19, 400 (88.30%) responded to our calls and agreed to participate in the study. Among them, 276 patients reported using CIM to treat COVID-19 [prevalence: 69% (95% CI: 64.2 to 73.5)]. The most frequently used herbal medicine among COVID-19 patients was ginger (n = 273, 98.9%), thyme (n = 263, 95.3%), and black cumin (n = 205, 74.3%). Most of these patients were recommended to use herbal medicine by their families and friends (n = 96, 34.8%). Univariable logistic regression revealed that age under 50 years old, residency in urban areas (including the capital of the province and small cities), employment, academic education, and being an outpatient were statistically significant factors resulting in CIM usage. Multivariable logistic regression revealed that CIM use among outpatients was 3.65 times more than among inpatients. In addition, patients under 50 years old used CIM 85% more than older patients. Ultimately, only 9 (3.3%) patients consulted with their doctors regarding these medications. No side effects due to CIM use were reported.
CONCLUSION
Many patients with COVID-19 used CIM, but few consulted with their physicians in this regard. Therefore, physicians should ask their patients about CIM usage, and patients should also report their use of CIM therapies during their medical visits. Furthermore, age and hospitalization status affected CIM use among patients with COVID-19.
背景
补充和整合医学（CIM）通常被寻求缓解各种疾病的个体采用。本研究调查了 COVID-19 患者使用 CIM 的流行率和相关因素。
方法
在这项基于电话的横断面研究中，我们使用研究人员制作的清单从 2020 年 2 月至 6 月在伊朗法尔斯省收集了 COVID-19 患者使用 CIM 的数据。此外，我们还询问了患者对这些治疗方法的态度。
结果
在 453 名被诊断患有 COVID-19 的患者中，有 400 名（88.30%）接听了我们的电话并同意参加研究。其中，276 名患者报告使用 CIM 治疗 COVID-19[流行率：69%（95%置信区间：64.2 至 73.5）]。COVID-19 患者最常使用的草药是生姜（n=273，98.9%）、百里香（n=263，95.3%）和黑孜然（n=205，74.3%）。这些患者中的大多数人是由家人和朋友推荐使用草药的（n=96，34.8%）。单变量逻辑回归显示，年龄在 50 岁以下、居住在城市地区（包括省会和小城市）、就业、学历和门诊就诊是导致使用 CIM 的统计学显著因素。多变量逻辑回归显示，门诊患者使用 CIM 的可能性是住院患者的 3.65 倍。此外，50 岁以下的患者使用 CIM 的可能性比年龄较大的患者高 85%。最终，只有 9 名（3.3%）患者就这些药物咨询了他们的医生。没有报告因使用 CIM 而产生的副作用。
结论
许多 COVID-19 患者使用 CIM，但很少有人就此咨询过医生。因此，医生应该询问患者有关 CIM 使用的情况，患者也应该在就诊时报告他们使用 CIM 疗法的情况。此外，年龄和住院状况影响 COVID-19 患者使用 CIM。
Zotero 插件